tetano
Editor, Senior Moderator
Antiviral Res. 2018 Mar 21. pii: S0166-3542(17)30831-8. doi: 10.1016/j.antiviral.2018.03.007. [Epub ahead of print]
[h=1]Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.[/h] McKimm-Breschkin JL[SUP]1[/SUP], Barrett S[SUP]2[/SUP], Wong FYK[SUP]3[/SUP], Pudjiatmoko[SUP]4[/SUP], Azhar M[SUP]5[/SUP], Selleck P[SUP]6[/SUP], Davies KR[SUP]7[/SUP], Hartaningsih N[SUP]8[/SUP], McGrane J[SUP]9[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We have tested the in vitro susceptibility to the neuraminidase (NA) inhibitors of 96 highly pathogenic clade 2.1 A(H5N1) viruses from Indonesia, isolated between 2008 and 2011. HPAI virus samples obtained through the Influenza Virus Monitoring (IVM) surveillance program in Indonesia were tested for susceptibility to oseltamivir and zanamivir. The NAs of four viruses were identified as extreme outliers to oseltamivir, based on statistical analysis by box plots, with IC[SUB]50[/SUB] values ranging from 46-62 nM. The NAs of two of these viruses from Sumatra and Aceh, had an N294S substitution, while one virus from Sulawesi had an S246N NA substitution. The NAs of all four viruses showed a specific loss of slow binding to oseltamivir in an IC[SUB]50[/SUB] kinetics assay. As observed in our previous surveillance, there was only a minimal effect on the sensitivity to zanamivir or peramivir for these mutants or any of the other isolates tested. The continued circulation of subtype H5N1 viruses in avian species poses an on-going zoonotic threat. The fact that we continue to identify avian isolates with naturally occurring mutations conferring reduced oseltamivir susceptibility remains a concern, given oseltamivir will be a key antiviral in the event of a new pandemic emerging.
[h=4]KEYWORDS:[/h] Avian influenza; H5N1; Neuraminidase inhibitor; Oseltamivir; Resistance; Surveillance
PMID: 29574145 DOI: 10.1016/j.antiviral.2018.03.007
[h=1]Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.[/h] McKimm-Breschkin JL[SUP]1[/SUP], Barrett S[SUP]2[/SUP], Wong FYK[SUP]3[/SUP], Pudjiatmoko[SUP]4[/SUP], Azhar M[SUP]5[/SUP], Selleck P[SUP]6[/SUP], Davies KR[SUP]7[/SUP], Hartaningsih N[SUP]8[/SUP], McGrane J[SUP]9[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We have tested the in vitro susceptibility to the neuraminidase (NA) inhibitors of 96 highly pathogenic clade 2.1 A(H5N1) viruses from Indonesia, isolated between 2008 and 2011. HPAI virus samples obtained through the Influenza Virus Monitoring (IVM) surveillance program in Indonesia were tested for susceptibility to oseltamivir and zanamivir. The NAs of four viruses were identified as extreme outliers to oseltamivir, based on statistical analysis by box plots, with IC[SUB]50[/SUB] values ranging from 46-62 nM. The NAs of two of these viruses from Sumatra and Aceh, had an N294S substitution, while one virus from Sulawesi had an S246N NA substitution. The NAs of all four viruses showed a specific loss of slow binding to oseltamivir in an IC[SUB]50[/SUB] kinetics assay. As observed in our previous surveillance, there was only a minimal effect on the sensitivity to zanamivir or peramivir for these mutants or any of the other isolates tested. The continued circulation of subtype H5N1 viruses in avian species poses an on-going zoonotic threat. The fact that we continue to identify avian isolates with naturally occurring mutations conferring reduced oseltamivir susceptibility remains a concern, given oseltamivir will be a key antiviral in the event of a new pandemic emerging.
[h=4]KEYWORDS:[/h] Avian influenza; H5N1; Neuraminidase inhibitor; Oseltamivir; Resistance; Surveillance
PMID: 29574145 DOI: 10.1016/j.antiviral.2018.03.007